FeesSafety
Pluang+
Home/News Feed/INOVIO to present at two major healthcare investor conferences in September 2026
INO
$0.80
+$0.00 +0.60%

INOVIO to present at two major healthcare investor conferences in September 2026

Market News
01 Sep 2026
PRNewsWire
View Source
Neutral
INOVIO to present at two major healthcare investor conferences in September 2026

INOVIO, a biotechnology company specializing in DNA medicines for HPV-related diseases, cancer, and infectious diseases, announced its participation in two upcoming investor conferences in New York: the Cantor Global Healthcare Conference on September 9 and the H.C. Wainwright 28th Annual Global Investment Conference starting September 11. The company will host a fireside chat and virtual presentations, with replays available for 90 days. These events provide INOVIO an opportunity to engage with investors and showcase its innovative DNA medicine technology.

More News (INO)

INOVIO wins $80M judgment against VGXI and GeneOne for contract breach in DNA plasmid manufacturing case

INOVIO wins $80M judgment against VGXI and GeneOne for contract breach in DNA plasmid manufacturing case

INOVIO Pharmaceuticals secured a court judgment awarding $80.4 million against VGXI and GeneOne for breaching a supply agreement related to DNA plasmid manufacturing. The court granted $61.75 million in compensatory damages and $18.67 million in fees...

Market News
Bullish
1 day ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App